[1] |
LI Qinghua, ZHAO Yan, ZHAO Haigang, GAO Pengfei, XU Bingxin.
Value of ABCB1 G2677T gene polymorphism detection in lipid-lowering therapy with atorvastatin in patients suffered from ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 633-640.
|
[2] |
ZHAO Lu, LI Fuyong, WEN Binhong, LI Daowei.
Effects of stains on hyperlipidemia and pain relieve of patients with chronic migraine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 671-675.
|
[3] |
LIANG Meifang, CHEN Qingzhuang, YANG Peiqun, WANG Yong.
Efficacy and safety of generic and branded atorvastatin in patients with ischemic stroke/transient ischemic attack: A real-world study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 785-792.
|
[4] |
WANG Zhen, QUAN Haiyan, HONG Chenliang, YUAN Lijialong, QIN Xuping.
Swimming improves renal function of diabetic mice by promoting autophagy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 632-638.
|
[5] |
HE Huan, XUE Zhenyu, MAO Haoli, ZHANG Lei.
Effects of prolonged sevoflurane exposure on metabolomics of prefrontal cortex in aged mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1375-1380.
|
[6] |
XU Ke, GAO Junwei, LIU Peng, SHEN Zhengri, JIA Hui, WU Chenguang, TIAN Feng, WANG Lifan, LI Ping.
Tangshen formula improves cholesterol uptake and efflux of macrophages induced by high lipid via activating PGC-1α/LXR/ABCA1 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 978-985.
|
[7] |
KONG Xiang, HUA Qiang, YAO Xinming, MENG Xiangjian, ZHONG Min, GUO Liqun.
Sesamol improves inflammation and insulin resistance in adipose tissue of obese mice by regulating macrophage polarization
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 728-733.
|
[8] |
WU Furong, NING Lijuan, ZHOU Ran.
Protective effects of Xiaochaihu Decoction on chemical hepatic fibrosis in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 481-488.
|
[9] |
XIE Xiangmei, HUANG Zhihong, LIU Xiaoju, XUE Bing, LAN Baozhu.
Effects of atorvastatin and folic acid tablets on homocysteine and carotid atherosclerosis in patients with type H hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 455-459.
|
[10] |
LI Jiadan,LU Chen.
Synergistic effects of Cortex Mori alkaloids combined with Simvastatin in rats with hyperlipidaemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 278-284.
|
[11] |
YUAN Li, HAN Lingna, CHANG Yongli, ZHANG Cuiying.
Study on GIP analogues against the cognitive impairments in APP/PS1 transgenic mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 721-729.
|
[12] |
CAI Miaoguo, SHAO Wei, YU Huijun, HONG Ye, SHI Lili.
Effects of regulation ROS on the pain and the protein of Pink1 in spinal of SNI mice and its mechannism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1263-1268.
|
[13] |
ZHENG Li, MO Juanfen, WU Jiayuan, GUO Li, BAO Yi.
Study on the anti-hyperlipidemia mechanisms and signaling pathways of traditional Chinese medicine Polygonum cuspidatum based on network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1107-1119.
|
[14] |
HUANG Lijia, HUANG Yang, KONG Jinsong, ZHENG Xin, GONG Xiaokang, RUAN Jianwei, WANG Haibao.
Inhibition of articular cartilage degeneration by atorvastatin calcium via STAT1-caspase-3 signaling axis in rats with knee osteoarthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 743-748.
|
[15] |
YANG Yi,GUAN Qiaobin,GUO Li,HAN Chenyang.
Antrodia camphorata polysaccharide improved neurobehavioral function in Parkinson mice via reducing the expression of NLRP3-Caspase1 inflammatory body
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 406-412.
|